Results 61 to 70 of about 4,323 (166)
Calcium channel autoantibodies in the lambert‐eaton myasthenic syndrome
, 1991 We have tested 36 patients with the Lambert‐Eaton myasthenic syndrome for serum antibodies to voltage‐gated calcium channels by using an immunoprecipitation assay with [125I] ω‐conotoxin–labeled voltage‐gated calcium channels extracted from a human ...
Newsom-Davis, John +7 more
core +1 more source
Clinical and genetic basis of congenital myasthenic syndromes
Arquivos de Neuro-PsiquiatriaNeuromuscular junction disorders represent a wide group of neurological diseases characterized by weakness, fatigability and variable degrees of appendicular, ocular and bulbar musculature involvement.
Paulo Victor Sgobbi de Souza +5 more
doaj +1 more source
Guillain‐Barré syndrome: a comprehensive review
European Journal of Neurology, Volume 31, Issue 8, August 2024.Abstract Guillain‐Barré syndrome (GBS) is a potentially devastating yet treatable disorder. A classically postinfectious, immune‐mediated, monophasic polyradiculoneuropathy, it is the leading global cause of acquired neuromuscular paralysis. In most cases, the immunopathological process driving nerve injury is ill‐defined.
Roberto Bellanti, Simon Rinaldi
wiley +1 more source
Clinical and functional studies of autoimmune disorders of neuromuscular transmission
, 2015 Inherited and acquired disorders of the neuromuscular junction are an important cause of muscle weakness and fatigability. In this thesis I focus on the autoimmune disorders of neuromuscular transmission.
Spillane, J
core
NMR‐based metabolomic investigation of dogs with acute flaccid paralysis due to tick paralysis
Veterinary Medicine and Science, Volume 10, Issue 4, July 2024.The NMR‐based serum metabolomics approach used in this study revealed distinct up‐regulated/down‐regulated expressions, presenting a promising avenue for research. It was observed that energy metabolism, particularly liver function, was impaired in dogs with tick paralysis.
Erdem Gülersoy +4 more
wiley +1 more source
Lambert-Eaton Myasthenic Syndrome Caused by Nivolumab in a Patient with Squamous Cell Lung Cancer
Case Reports in Neurology, 2018 Lambert-Eaton myasthenic syndrome (LEMS) is a representative paraneoplastic neurological syndrome. Recently, nivolumab, an anti-programmed cell death 1 inhibitor, has been approved for advanced non-small-cell lung cancer. Careful attention should be paid
Yuki Nakatani +5 more
doaj +1 more source
Clinical Case Reports, Volume 12, Issue 6, June 2024.Key Clinical Message The co‐occurrence of myasthenia gravis (MG) and lichen planus (LP) is a rare phenomenon, with only 13 cases reported in the English literature between 1971 and 2024. Patients with MG or LP, regardless of the thymoma status, require close monitoring for other autoimmune diseases.
Melika Jameie +5 more
wiley +1 more source
Lambert-Eaton Myasthenic Syndrome And The Eye
, 2013 Wide ranges on the frequency of ophthalmic symptoms and signs in Lambert-Eaton Myasthenic Syndrome (LEMS) have led to mixed and occasionally contradictory messages on how frequenly the visual system is ...
Jeffery D. Young; Jacqueline A. Leavitt; David O. Hodge
core
Idiopathic Lambert-Eaton myasthenic syndrome. Report of one case Síndrome miasteniforme de Lambert-Eaton idiopático [PDF]
, 2006 Lambert-Eaton myasthenic syndrome (LEMS) is an autoinmune idiopathic or paraneoplastic syndrome producing antibodies agaisnt presynaptic voltage calcium channels.
Luis Pedraza, C. +3 more
core
Paraneoplastic neurological syndromes
Orphanet Journal of Rare Diseases, 2007 Paraneoplastic neurological syndromes (PNS) can be defined as remote effects of cancer that are not caused by the tumor and its metastasis, or by infection, ischemia or metabolic disruptions.
Antoine Jean-Christophe +1 more
doaj +1 more source